Associate Director, Business Development

About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland. Overview of Role: The Associate Director, Business Development plays a critical role in advancing the company’s external innovation strategy by identifying, evaluating, and supporting the execution of strategic partnerships or combinations opportunities. This role reports to the Director BD, works closely with the VP BD and Strategic Alliances, partners with the Alliance Management Lead and engages cross-functional teams to drive company growth through external collaborations & joint clinical trials. The ideal candidate brings strong scientific & business acumen, transaction & alliance experience, and the ability to navigate complex strategic landscapes with speed, rigor, and creativity. This is a hands-on, end-to-end experience role, where you’ll engage on strategy, searching and securing opportunities, communicate with external companies, tactically progress contracting, as well as contribute to the department’s maintenance of strategic alliances. Role and Responsibilities: Strategy & Scenario Planning Maintain a deep understanding of the oncology competitive landscape, emerging modalities, and deal trends to inform BD strategy and prioritization. Partner with internal experts and strategy team members to shape future scenarios and action plans. Search & Evaluation Evaluate external assets, companies, platforms, and technologies aligned with the company’s oncology strategy and pipeline needs. Ability to triangulate, prioritize opportunities and conduct robust financial and qualitative business case analysis. Transaction Support & Execution Support or lead deal processes including diligence, external communication with potential collaborators, coordinating contracting and related requirements, and preparation of executive materials. Alliance & Relationship Management Contribute to collaboration alliance activities or clinical trial project oversight with partner, governance and performance tracking of key alliances, ensuring alignment with strategic objectives and operational milestones. Executive Communicati…